Savings Effect

ICICI Securities’ Muhurat picks: Venus Pipes leads 10-stock list with up to 34% upside ICICI Securities has selected 10 stocks for Muhurat trading and Samvat 2083, with Venus Pipes and Tubes offering the highest potential upside of 34%, followed by Neogen Chemicals at 32% and Info Edge at 28%; the basket has an average implied upside of around 23%.

China extends gold buying spree to two years as prices drop, adds 25.8 tonnes in October China's central bank added 25.8 tonnes of gold to its reserves in October, extending its buying streak to 24 months, even as bullion prices fell nearly 7% during the month.

Coca-Cola India bottling arm HCCB's parent files DRHP with SEBI for IPO Hindustan Coca-Cola Holdings, the parent of Coca-Cola's Indian bottling arm HCCB, has filed its DRHP with SEBI for an IPO comprising an offer for sale of nearly 99.75 crore shares, with a proposed listing on the BSE and NSE in 2027.

US SUSPECTS NVIDIA CEO JENSEN HUANG HAD ROMANTIC TIES TO ALLEGED CHINESE SPY

DIVISLAB: Q2 CONS NET PROFIT 11.27B RUPEES VS 6.89B (YOY) DIVISLAB: Q2 EBITDA 15.66B RUPEES VS 8.88B (YOY); Q2 EBITDA MARGIN 42.60% VS 32.71% (YOY) DIVISLAB: Q2 REVENUE 36.76B RUPEES VS 27.15B (YOY)

DCMSRIND: Q2 STANDALONE NET PROFIT 130.2M RUPEES VS 34.7M (YOY) DCMSRIND: Q2 EBITDA 252M RUPEES VS 132M (YOY); Q2 EBITDA MARGIN 8.1% VS 3.92% (YOY) DCMSRIND: Q2 REVENUE 3.1B RUPEES VS 3.3B (YOY)

MAWANASUG: Q2 STANDALONE NET LOSS 31M RUPEES VS LOSS 161.3M (YOY) MAWANASUG: Q2 EBITDA 29.6M RUPEES VS LOSS 101.3M (YOY); Q2 EBITDA MARGIN 0.77% MAWANASUG: Q2 REVENUE 3.86B RUPEES VS 4.29B (YOY)

MUKKA: Q2 CONS NET PROFIT 159.9M RUPEES VS 58.8M (YOY) MUKKA: Q2 EBITDA 422.7M RUPEES VS 207.2M (YOY); Q2 EBITDA MARGIN 8.31% VS 8.47% (YOY) MUKKA: Q2 REVENUE 5.09B RUPEES VS 2.45B (YOY)

POWER MECH PROJECTS: CO'S SAUDI UNIT BAGS ₹387 CRORE RABIGH 2 IPP EXPANSION CONTRACT